- Home
- Industries
Aerospace And Defence
Agriculture
Automotive And Transportation
Banking And Finance
Business
Chemicals And Materials
Consumer And Retail
Electronics And Semiconductors
Food And Beverages
Machinery & Equipments
Manufacturing And Construction
Medical Devices
Others
Pharmaceuticals And Healthcare
Power And Energy
Sports
Technology
- Services
- News Room
- About us
- Contact Us
-
Global In-vitro fertilization (IVF) Industry Market Dynamics & Strategic Insights 2021-2030
In-Vitro Fertilization (IVF) is various assisted reproductive techniques that are used to treat infertile couples who are not able to conceive after two years of sexual contact without the use of birth control. There are some reasons for infertility are endometriosis, hormonal imbalance, blocked or damaged fallopian tubes in women, and low sperm count in males. In-Vitro Fertilization will not work those women are not capable of ovulating and man who is not able to produce few healthy sperm. Though In-Vitro Fertilization (IVF) should be considered as the last option, if other treatments for these conditions, like surgery for choked tubes or endometriosis, maybe tried before starting in the Vitro fertilization process.
Global In-Vitro Fertilization (IVF) Market іѕ ѕеgmеntеd on the bаѕіѕ оf Technology (Intra-cytoplasmic Sperm Injection (ICSI), Pre-implantation Genetic Diagnosis (PGD), and Frozen Embryo Transfer/ Replacement (FER)), Product (Reagent, Equipment, and Others), End-User (Fertility and Surgical Centers, Hospitals and Research laboratories, and Cryobanks) and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa).
The Global In-Vitro Fertilization (IVF) Market wаѕ vаluеd аt UЅD 15.876 Мn іn 2020 іѕ рrојесtеd tо іnсrеаѕе ѕіgnіfісаntlу аt а САGR оf 10.2% frоm 2021 tо 2030.
The report on Global In-Vitro Fertilization (IVF) Market which оffеrѕ іn-dерth аnаlуѕіѕ оn mаrkеt drіvеrѕ, rеѕtrаіntѕ, орроrtunіtіеѕ, trеndѕ, and other important information regarding the Global In-Vitro Fertilization (IVF) Market. This rероrt іnсludеs quаlіtаtіvе іnfоrmаtіоn and quаntіtаtіvе аnаlуѕіѕ оf vаrіоuѕ ѕеgmеntѕ іn tеrmѕ оf mаrkеt ѕhаrе, grоwth, орроrtunіtу аnаlуѕіѕ, mаrkеt value, еtс. fоr thе fоrесаѕt уеаrѕ. The report offers detailed information regarding the various key players operating in the Global In-Vitro Fertilization (IVF) Market, their financials, key developments, supply chain trends, technological innovations, apart from future strategies, acquisitions & mergers, market footprint, and COVID-19 Analysis. This report is based on analysis, synthesis, and interpretation of the information gathered regarding the Global In-Vitro Fertilization (IVF) Market from various sources. We analyzed the data and information and gained insights using primary and secondary research efforts with the primary objective order to provide a holistic view of the Global In-Vitro Fertilization (IVF) Market.
Market Dynamics:
Growing awareness about infertility, the rising rate of infertility, increasing health care expenditure, and easy availability of IVF treatments and advancement in technology such as capsule IVF and embryo scope, insurance coverage for IVF are factors expected to drive the growth of the global in-vitro fertilization market. Also, changing lifestyle, improper food habits, late-night and stressful working hours, rising alcohol consumption among individuals are expected to propel the growth of the global market.
However, the risk of failure associated with IVF cycles, physical and emotional stress due to financial burden are factors probable to restrain the target market.
Stringent rules and regulations, restrictions on the availability of IVF, high cost for in vitro fertilization treatment have given the increase in fertility tourism. Also, medical tourism is provided with an excellent opportunity for the growth of the in-vitro fertilization market in many developing countries.
Segmental Analysis:
Among the technology segments, the Intra-cytoplasmic Sperm Injection (ICSI) segment is accounted for a major revenue share and is expected to maintain its dominance in the global market.
Among the product segments, the reagents segment holds the largest share in the global in-vitro fertilization market. This is due to the increasing number of IVF procedures that lead to an increase in the usage of reagents.
Among the end-user segments, the fertility and surgical centers segment accounts for a major share and will continue to be the fastest-growing segment in the global market during the forecast period, owing to rising demand for ART treatments, the number of fertility clinics, and ART centers are increasing significantly.
Regional Analysis:
Europe market is expected to dominate the global in-vitro fertilization market in revenue terms and is estimated for the largest revenue share in other regions. This is primarily attributed to the increasing demand for smooth implementation of advanced technology, ART procedures, and the rising adoption of in vitro babies among the population. Moreover, increasing PCOS and obesity rates, rising obesity rates, declining birthrates, favorable regulatory amendments for IVF, and the rise of IVF tourism in the countries such as France, Italy, Germany in the region. Asia Pacific region is expected to hold the highest growth rate during the forecast period, owing to the growing prevalence of PCOS, the abolishment of China’s one-child policy, high maternal age, rising fertility tourism in Thailand and India in this region.
Global In-Vitro Fertilization (IVF) Market Segmentation:
Segmentation by Technology:
• Intra-cytoplasmic Sperm Injection (ICSI)
• Pre-implantation Genetic Diagnosis (PGD)
• Frozen Embryo Transfer/ Replacement (FER)
• Others (Assisted hatching, intrauterine insemination, donor insemination and in vitro maturation)
Segmentation by Product:
• Reagent
• Equipment
• Others
Segmentation by End User:
• Fertility and Surgical Centers
• Hospitals and Research laboratories
• Cryobanks
Segmentation by region:
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Key Players:
CooperSurgical Inc.
Vitrolife AB
Cook Medical Inc.
Irvine Scientific
Thermo Fisher Scientific Inc.
ESCO Micro Pte. Ltd.
Genea Limited
The Baker Company
IVFtech ApS
EMD Serono Inc.
Global In-Vitro Fertilization (IVF) Market іѕ ѕеgmеntеd on the bаѕіѕ оf Technology (Intra-cytoplasmic Sperm Injection (ICSI), Pre-implantation Genetic Diagnosis (PGD), and Frozen Embryo Transfer/ Replacement (FER)), Product (Reagent, Equipment, and Others), End-User (Fertility and Surgical Centers, Hospitals and Research laboratories, and Cryobanks) and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa).
The Global In-Vitro Fertilization (IVF) Market wаѕ vаluеd аt UЅD 15.876 Мn іn 2020 іѕ рrојесtеd tо іnсrеаѕе ѕіgnіfісаntlу аt а САGR оf 10.2% frоm 2021 tо 2030.
The report on Global In-Vitro Fertilization (IVF) Market which оffеrѕ іn-dерth аnаlуѕіѕ оn mаrkеt drіvеrѕ, rеѕtrаіntѕ, орроrtunіtіеѕ, trеndѕ, and other important information regarding the Global In-Vitro Fertilization (IVF) Market. This rероrt іnсludеs quаlіtаtіvе іnfоrmаtіоn and quаntіtаtіvе аnаlуѕіѕ оf vаrіоuѕ ѕеgmеntѕ іn tеrmѕ оf mаrkеt ѕhаrе, grоwth, орроrtunіtу аnаlуѕіѕ, mаrkеt value, еtс. fоr thе fоrесаѕt уеаrѕ. The report offers detailed information regarding the various key players operating in the Global In-Vitro Fertilization (IVF) Market, their financials, key developments, supply chain trends, technological innovations, apart from future strategies, acquisitions & mergers, market footprint, and COVID-19 Analysis. This report is based on analysis, synthesis, and interpretation of the information gathered regarding the Global In-Vitro Fertilization (IVF) Market from various sources. We analyzed the data and information and gained insights using primary and secondary research efforts with the primary objective order to provide a holistic view of the Global In-Vitro Fertilization (IVF) Market.
Market Dynamics:
Growing awareness about infertility, the rising rate of infertility, increasing health care expenditure, and easy availability of IVF treatments and advancement in technology such as capsule IVF and embryo scope, insurance coverage for IVF are factors expected to drive the growth of the global in-vitro fertilization market. Also, changing lifestyle, improper food habits, late-night and stressful working hours, rising alcohol consumption among individuals are expected to propel the growth of the global market.
However, the risk of failure associated with IVF cycles, physical and emotional stress due to financial burden are factors probable to restrain the target market.
Stringent rules and regulations, restrictions on the availability of IVF, high cost for in vitro fertilization treatment have given the increase in fertility tourism. Also, medical tourism is provided with an excellent opportunity for the growth of the in-vitro fertilization market in many developing countries.
Segmental Analysis:
Among the technology segments, the Intra-cytoplasmic Sperm Injection (ICSI) segment is accounted for a major revenue share and is expected to maintain its dominance in the global market.
Among the product segments, the reagents segment holds the largest share in the global in-vitro fertilization market. This is due to the increasing number of IVF procedures that lead to an increase in the usage of reagents.
Among the end-user segments, the fertility and surgical centers segment accounts for a major share and will continue to be the fastest-growing segment in the global market during the forecast period, owing to rising demand for ART treatments, the number of fertility clinics, and ART centers are increasing significantly.
Regional Analysis:
Europe market is expected to dominate the global in-vitro fertilization market in revenue terms and is estimated for the largest revenue share in other regions. This is primarily attributed to the increasing demand for smooth implementation of advanced technology, ART procedures, and the rising adoption of in vitro babies among the population. Moreover, increasing PCOS and obesity rates, rising obesity rates, declining birthrates, favorable regulatory amendments for IVF, and the rise of IVF tourism in the countries such as France, Italy, Germany in the region. Asia Pacific region is expected to hold the highest growth rate during the forecast period, owing to the growing prevalence of PCOS, the abolishment of China’s one-child policy, high maternal age, rising fertility tourism in Thailand and India in this region.
Global In-Vitro Fertilization (IVF) Market Segmentation:
Segmentation by Technology:
• Intra-cytoplasmic Sperm Injection (ICSI)
• Pre-implantation Genetic Diagnosis (PGD)
• Frozen Embryo Transfer/ Replacement (FER)
• Others (Assisted hatching, intrauterine insemination, donor insemination and in vitro maturation)
Segmentation by Product:
• Reagent
• Equipment
• Others
Segmentation by End User:
• Fertility and Surgical Centers
• Hospitals and Research laboratories
• Cryobanks
Segmentation by region:
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Key Players:
CooperSurgical Inc.
Vitrolife AB
Cook Medical Inc.
Irvine Scientific
Thermo Fisher Scientific Inc.
ESCO Micro Pte. Ltd.
Genea Limited
The Baker Company
IVFtech ApS
EMD Serono Inc.
Scope:
| Report Data | Market |
| Forecast 2022 | XX million/billion (2022-2032) |
| CAGR 2022 - 2032 | % |
| Analysis Period | 2022 - 2032 |
| Base Year | 2021 |
| Forecast Data | 2022 - 2032 |
| Segments Covered | By Type, By Application, And by Regions |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled | . |
| Key Segments | By Type By Applications |
| Report Coverage | Market Drivers, Market Trends, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
Frequently Asked Questions
What is the future market value of the ?
The current market value for is expected USD XX million/billion by 2022.
What is the CAGR of the Market?
The is to grow at a CAGR of 5.3% during the forecast by 2032.
What is the Market segment?
On the basis of type, the is segmented into Types.
Who are the key players operating in the ?
The major players operating in the are Company.
Select Licence Type
Connect with our sales team
Why Future Market Outlook
100%
Customer
Satisfaction
24x7+
Availability - we are always
there when you need us
200+
Fortune 50 Companies trust
Future Market Outlook
80%
of our reports are exclusive
and first in the industry
100%
more data
and analysis
1000+
reports published
till date
